Exane Derivatives’s ICU Medical ICUI Stock Holding History

Exane Derivatives’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$164	Hold	1	–	–	﹤0.01%	689
2022 Q1	$223	Hold	1	–	–	﹤0.01%	954
2021 Q4	$237	Sell	1 -226	-100%	-$52.8K	﹤0.01%	830
2021 Q3	$53K	Sell	227 -79	-26%	-$16.6K	0.01%	613
2021 Q2	$62.4K	Sell	306 -945	-76%	-$194K	0.01%	617
2021 Q1	$257K	Buy	1,251 +74	+6%	+$15.6K	0.07%	257
2020 Q4	$252K	Buy	1,177 +701	+147%	+$136K	0.07%	275
2020 Q3	$87K	Buy	476 +458	+2,544%	+$86.2K	0.03%	320
2020 Q2	$3.32K	Sell	18 -489	-96%	-$97.1K	﹤0.01%	475
2020 Q1	$102K	Buy	507 +498	+5,533%	+$95.9K	0.03%	279
2019 Q4	$1.75K	Buy	9 +5	+125%	+$860	﹤0.01%	509
2019 Q3	$638	Hold	4	–	–	﹤0.01%	567
2019 Q2	$1.01K	Hold	4	–	–	﹤0.01%	560
2019 Q1	$957	Sell	4 -1,945	-100%	-$466K	﹤0.01%	501
2018 Q4	$447K	Buy	1,949 +1,462	+300%	+$360K	0.08%	183
2018 Q3	$139K	Hold	487	–	–	0.03%	285
2018 Q2	$143K	Hold	487	–	–	0.02%	290
2018 Q1	$120K	Buy	487 +23	+5%	+$5.41K	0.02%	278
2017 Q4	$100K	Buy	+464	New	+$93.9K	0.02%	300

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Exane Derivatives's ICUI Position: Q2 2022 in Review

Exane Derivatives held its ICU Medical (ICUI) position steady in Q2 2022 at 1 share worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Exane Derivatives first reported a position in ICUI in Q4 2017 and has held it in 19 quarters since. The position peaked at $447K in Q4 2018. 256 funds tracked by Wall St. Rank hold ICUI as of Q2 2022.

Exane Derivatives held 1 share of ICU Medical worth $164 as of Q2 2022.
Exane Derivatives left its ICU Medical share count unchanged in Q2 2022.
ICU Medical made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #689 holding.
Exane Derivatives first reported a position in ICU Medical in Q4 2017 and has held it in 19 quarters since.
Exane Derivatives's ICU Medical position peaked at $447K in Q4 2018.
256 funds tracked by Wall St. Rank held ICU Medical as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.